Company news
Sichuan Huiyu Pharmaceutical Co. Ltd. Class A (SSE:688553) news
Sichuan Huiyu Pharmaceutical Co. Ltd. Class A news releases on 6ix. Latest, Nov 22, 2025: Announcement on Voluntary Disclosure of the Acceptance of IND…
Press releases — page 2
Announcement on Voluntary Disclosure of the Acceptance of IND Application for the Drug Combination Involving HYP-6589 Tablets
November 21, 2025
Announcement on Obtaining Drug Registration Certificate for Etoposide Injecton
November 14, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 6, 2025
Announcement on Participation of the Company and Its Related Parties in Private Equity Fund Investment and Related Party Transaction
October 29, 2025
Announcement on Voluntary Disclosure of Prospective Winning in the National Centralized Drug Procurement
October 28, 2025
Announcement on Judicial and Rotary Freezing of Shares Held by Shareholder with Over 5% Shares
October 10, 2025
Announcement on Progress in Providing Guarantees for Wholly-owned Subsidiary
October 9, 2025
Announcement on Intending to Provide Guarantee for Wholly-owned Subsidiaries
September 26, 2025
Announcement on Rotary Freezing of Partial Shares Held by Shareholder with Over 5% Shares
September 22, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
September 15, 2025
Announcement on Resolutions of the Board of Directors
August 29, 2025
Announcement on the Proposed Signing of a National General Distribution Agreement and Related Party Transactions
August 26, 2025
Announcement on Release of Freezing and Freezing of Partial Shares Held by Shareholder with Over 5% Shares
August 14, 2025
Announcement on Voluntary Disclosure of Administration of the First Subject to the Phase 1 Clinical Trial of HY05350 for Injection
August 4, 2025
Announcement on Voluntary Disclosure of Administration of the First Subject to the Phase 1 Clinical Trial of HY0001a for Injection
July 30, 2025
Announcement on Expiration of Plan of Shareholding Reduction by Shareholder with Over 5% Shares and Results of Shareholding Reduction
July 25, 2025
Announcement on Resolutions of the Board of Supervisors
July 15, 2025